2026年6月最新影响因子数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎反馈给我们。
![]() |
体验更多LetPub AI科研工具 >> | |
| 近期推荐: | 热 Wiley 2026暑期线上学习营 | 报名正式开启! | 热 多本ABS四星!优质经管国际期刊列表 | 新 Springer Nature生物医学与生命科学资源合集 | 附免费书单 |
| |
| 基本信息 | 登录收藏 | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字![]() | BMC CANCER BMC CANCER (此期刊被最新的JCR期刊SCIE收录) LetPub评分 6.5
90人评分
我要评分
声誉 6.9 影响力 5.9 速度 6.8 | |||||||||||||||||||||||||
| 期刊ISSN | 1471-2407 | 安装APP,查看期刊最新消息
| ||||||||||||||||||||||||
| 2025-2026最新IF (数据来源于网友提供) | 注册或登录后,查看IF | |||||||||||||||||||||||||
| 实时影响因子 | 截止2026年5月06日:4.1 | |||||||||||||||||||||||||
| 2025-2026自引率 | 2.4%点击查看自引率趋势图 | |||||||||||||||||||||||||
| 五年IF (数据来源于网友提供) | 4.096数据由网友[magicsnow453]收集提供 | |||||||||||||||||||||||||
| h-index | 111 | |||||||||||||||||||||||||
| CiteScore ( 2026年6月最新版) |
| |||||||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||||||
| 期刊官方网站 | https://link.springer.com/journal/12885
投稿规范预检(避免 Desk Rejection) 开始检查>>
| |||||||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||||||
| 期刊投稿网址 | https://author-welcome.nature.com/12885
AI辅助快速完成投稿信初稿 一键撰写投稿信>>
| |||||||||||||||||||||||||
| 作者指南网址 | https://link.springer.com/journal/12885/collections
提前检查论文语言风险 AI 写作痕迹检测>>
| |||||||||||||||||||||||||
| 该期刊中国学者近期发文 - New | AHSP as a novel non-invasive urinary biomarker for prostate cancer (vol 26, 574, 2026) Author: Wang, Chen; Zhang, Yang-yang; Wang, Hong-qun; Huang, Cong; Yu, Na; Yan, Huang; Zhu, Ya-nan; Yan, De-lun Journal: BMC CANCER. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12885-026-16260-3 Efficacy and risk analysis of monotherapy and dual immunotherapy in dMMR/MSI-H metastatic colorectal cancer: a meta-analysis based on randomized controlled trials Author: Wang, Shengqian; Gu, Renjun; Lu, Jiajie; Wang, Shenghao; Tao, Sijia; Zhang, Xiaoyu; Chen, Lerou; An, Yongming; Gu, Xin; Li, Ziyun; Qu, Minye Journal: BMC CANCER. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12885-026-16033-y FGFR4-high expression is associated with an immune-responsive phenotype in HCC and predicts inferior efficacy of lenvatinib plus PD-1 blockade Author: Wei, Fuqun; Liu, Weifu; Chen, Zhisheng; Chen, Zhongwu; Liu, Jingfeng Journal: BMC CANCER. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12885-026-16098-9 Aumolertinib in non-small cell lung cancer with uncommon EGFR exon 19 deletions: a real-world dual-center study Author: Yang, Guangjian; Tian, Linyan; He, Dongsheng; Hu, Jiaqi; Wei, Fang; Li, Weihua; Li, Pei; Qiu, Huanbing; Tang, Xiaoyong; Wang, Yan Journal: BMC CANCER. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12885-026-16119-7 | |||||||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足BMC CANCER的语言要求,还能让BMC CANCER编辑和审稿人得到更好的审稿体验,让稿件最大限度地被BMC CANCER编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢(11篇) 。
提交文稿 | |||||||||||||||||||||||||
| 是否OA开放访问 | Yes | |||||||||||||||||||||||||
OA期刊相关信息![]() | 文章处理费:需要( GBP2690; USD3550; EUR3150; ) 文章处理费豁免:查看说明 其他费用:没有 期刊主题关键词:cancer 相关链接:Aims & ScopeAuthor InstructionsEditorial BoardOpen peer review | |||||||||||||||||||||||||
| 通讯方式 | BIOMED CENTRAL LTD, 236 GRAYS INN RD, FLOOR 6, LONDON, ENGLAND, WC1X 8HL | |||||||||||||||||||||||||
| 出版商 | BioMed Central | |||||||||||||||||||||||||
| 涉及的研究方向 | 医学-肿瘤学 | |||||||||||||||||||||||||
| 出版国家或地区 | ENGLAND | |||||||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||||||
| 出版周期 | Irregular | |||||||||||||||||||||||||
| 出版年份 | 2001 | |||||||||||||||||||||||||
| 年文章数 | 2065点击查看年文章数趋势图 | |||||||||||||||||||||||||
| Gold OA文章占比 | 99.96% | |||||||||||||||||||||||||
| 研究类文章占比: 文章 ÷(文章 + 综述) | 93.22% | |||||||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版:不在预警名单中 2025年03月发布的2025版:不在预警名单中 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||||||
| 《新锐期刊分区表》 ( 2026年3月发布) | 点击查看期刊分区表趋势图
| |||||||||||||||||||||||||
| 期刊分区表 ( 2025年3月升级版) |
| |||||||||||||||||||||||||
| 期刊分区表 ( 2023年12月旧的升级版) |
| |||||||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1471-2407%5BISSN%5D | |||||||||||||||||||||||||
| 平均审稿速度 | 网友分享经验: 平均6.8月 | |||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验: 约38.12% | |||||||||||||||||||||||||
| 版面费/APC文章处理费信息 | 文章处理费:需要( GBP2690; USD3550; EUR3150; ) 文章处理费豁免:查看说明 其他费用:没有 LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦! | |||||||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在BMC CANCER顺利发表。
快看看作者怎么说吧:服务好评 论文致谢(11篇) 。 提交文稿 | |||||||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | AHSP as a novel non-invasive urinary biomarker for prostate cancer (vol 26, 574, 2026) Author: Wang, Chen; Zhang, Yang-yang; Wang, Hong-qun; Huang, Cong; Yu, Na; Yan, Huang; Zhu, Ya-nan; Yan, De-lun Journal: BMC CANCER. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12885-026-16260-3 PubMed DOI |
| 2. | Efficacy and risk analysis of monotherapy and dual immunotherapy in dMMR/MSI-H metastatic colorectal cancer: a meta-analysis based on randomized controlled trials Author: Wang, Shengqian; Gu, Renjun; Lu, Jiajie; Wang, Shenghao; Tao, Sijia; Zhang, Xiaoyu; Chen, Lerou; An, Yongming; Gu, Xin; Li, Ziyun; Qu, Minye Journal: BMC CANCER. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12885-026-16033-y PubMed DOI |
| 3. | FGFR4-high expression is associated with an immune-responsive phenotype in HCC and predicts inferior efficacy of lenvatinib plus PD-1 blockade Author: Wei, Fuqun; Liu, Weifu; Chen, Zhisheng; Chen, Zhongwu; Liu, Jingfeng Journal: BMC CANCER. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12885-026-16098-9 PubMed DOI |
| 4. | Aumolertinib in non-small cell lung cancer with uncommon EGFR exon 19 deletions: a real-world dual-center study Author: Yang, Guangjian; Tian, Linyan; He, Dongsheng; Hu, Jiaqi; Wei, Fang; Li, Weihua; Li, Pei; Qiu, Huanbing; Tang, Xiaoyong; Wang, Yan Journal: BMC CANCER. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12885-026-16119-7 PubMed DOI |
| 5. | Predicting prognosis and drug sensitivity in patients with hepatocellular carcinoma using an lncRNA signature associated with cuproptosis Author: Li, Yan; Lv, Shiyu; Wang, Yunqiu Journal: BMC CANCER. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12885-026-16132-w PubMed DOI |
| 6. | PPP4C: a potential molecular marker and therapeutic target in thyroid cancer and triple-negative breast cancer Author: Li, Huashui; Chen, Yifan; Guo, Guodong; Luo, Qinghua; Lin, Qiang; Xie, Wenjun; Yan, Maolin Journal: BMC CANCER. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12885-026-16083-2 PubMed DOI |
| 7. | Radiological differentiation of succinate dehydrogenase-deficient renal cell carcinoma from renal oncocytoma and chromophobe renal cell carcinoma Author: Wang, Guorong; Yu, Yanfei; Han, Yongliang; Wang, Kexin; Wu, Jingyun; Liu, Yi Journal: BMC CANCER. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12885-026-16112-0 PubMed DOI |
| 8. | CD109 is associated with an immunosuppressive microenvironment and M2 macrophage polarization: pan-cancer analysis and functional validation Author: Li, Fangqiong; Zhang, Wei; Gong, Xiaoting; Liu, Dan; You, Qi; Li, Ying; Zhao, Guizhi; Wang, Wei Journal: BMC CANCER. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12885-026-16100-4 PubMed DOI |
| 9. | A meta-analysis of dizziness as an adverse reaction in novel endocrine therapy for advanced prostate cancer Author: Xue, Wenbin; Zhang, Pu; Quan, Jing Journal: BMC CANCER. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12885-026-16101-3 PubMed DOI |
| 10. | Prognostic value of preoperative Prognostic Nutritional Index (PNI) versus Neutrophil Lymphocyte Ratio (NLR) in gastric-cancer patients: a retrospective cohort study Author: Li, Jie; Zhao, Haozong; Sun, Peiwei; Zhang, Qianshi; Liu, Zhong Journal: BMC CANCER. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12885-026-16106-y PubMed DOI |
|
|
|
投稿状态统计: 我要评分: | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范?试试稿件自查工具,一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验:共1204条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号:沪ICP备10217908号-1
沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室